National and Kapodistrian University of Athens
Μοριακή τυποποίηση στελεχών ειδών candida από συστηματικές μυκητιάσεις ανοσοκατασταλμένων ασθενών
Abstract
dc:descriptionDuring the last two decades, fungal infections caused by species of the genus Candida have turned out as a major medical as well as social problem in many countries of the Western World. It is thus imperative for the clinician as well as molecular biologist to come up with alternative and accurate laboratory solutions in terms of identification of the pathogenic fungus at the species level. In the present study, specific regions of the Candida genome were selected and analysed by use of a combined molecular methodology, with the hope of finding appropriate molecular markers for prompt identification of different Candida isolates both in terms of genus and species level. The conserved 5S rDNA genomic region together with the hypervariable ITS 1 and ITS 2 genomic regions, belonging to the rDNA genomic complex of the Candida genome, were analyzed by PCR and SSCP methods. These genomic markers were initially tested in 218 confirmed fungal isolates of the genus Candida belonging to the National Collection of Pathogenic Fungi (WFCC 2023) of the Mycology Reference Laboratory (Medical School, University of Athens) and afterwards in 108 biochemically confirmed Candida isolates from 64 immunocompromised and 22 non-immunosuppressed patients with confirmed or probable systematic infection by different Candida species, hospitalised in a central tertiary hospital in Athens. Molecular analysis of the 5S rDNA genomic region revealed a high discriminatory power (0.91), allowing the identification of 10 out of 11 different Candida species tested (C. albicans, C. parapsilosis, C. glabrata, C. tropicalis, C. krusei, C. rugosa, C. kefyr, C. pulcherimma, C. famata and C. guilliermondii). The SSCP banding pattern of C. dubliniensis was identical with C. albicans, rendering unable the identification at the molecular level. Sequencing results of the 10 species mentioned above revealed 8 cases of new sequences (all except C. albicans and C. parapsilosis). Furthermore, the same methodology was successfully tested in mixed DNA samples from 2 or 3 different Candida species. The ITS 1 genomic region was found to be conserved in C. albicans and hypervariable for C. tropicalis (4 SSCP subtypes) and C. parapsilosis (4 SSCP subtypes). On the other hand, the ITS 2 genomic region was found hypervariable in C. albicans with 8 SSCP subtypes, 5 of which were first described. The results of this study point out to 5S rDNA genomic region as an appropriate molecular marker for identification of different species of the genus Candida by use of the PCR-SSCP combined methodology. The ITS 2 genomic region can serve as a valuable diagnostic as well as epidemiological marker for identification of different C. albicans subtypes. On the other hand, ITS 1 region seems promising in identification of non-C. albicans subtypes, whereas this region appears highly conserved in C. albicans isolates. In terms of distribution of the 108 clinical samples of this study, 55% was C. albicans, 21% C. tropicalis and 9% C. glabrata. Patients hospitalized in the ICU or critically ill patients developed higher frequency of non-C.a fungal infections, whereas C.a isolates were found with greater abundance in immunocompromised patients. The results of this study showed C. tropicalis as the most abundant non-C.a species, especially amongst immunocompromised patients. It is of interest to note the elevated percentage of non-C.a isolates in the diseased patients and especially of C. krusei isolates (15%). More than one different Candida species were isolated in 18.6% of the total patient number and in 75% of the patients coexistence of fungal and bacterial infection was noted. Finally, it would be interesting from a clinical point of view to test specific C. albicans molecular subtypes in relation to resistance to specific antifungal drugs.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2007
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Tegos, Nikolaos
- Τέγος, Νικόλαος
Subjects
dc:subject × 17- Μυκητιάσεις
- Ασθενείς ανοσοκατασταλμένοι
- Πολυμέραση, Αλυσιδωτή αντίδραση
- DNA, Ανάλυση του πολυμορφισμού διαμόρφωσης του μονόκλωνου
- Candida, Τυποποίηση
- Candida, Ταυτοποίηση
- Patients, Immunocompromised
- Systemic candidiasis
- PCR
- SSCP
- Molecular typing
- Molecular markers
- SSCP subtypes
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/18640